At 24 weeks, participants receiving the highest dose achieved a mean body weight reduction of approximately 17.5%, representing some of the most substantial weight loss data observed in a Phase 2 obesity trial to date
This makes it a popular choice for those looking for mental clarity and cognitive support
When comparing metformin and semaglutide, the evidence points in a clear direction for most people who want meaningful weight loss
By activating GLP-1 receptors, these medications improve glucose-dependent insulin secretion, reduce appetite, delay gastric emptying, and promote earlier satiety, often resulting in reduced caloric intake and weight loss (7)
This usually happens because the body struggles to absorb standard oral glutathione
CLEC5A and TLR2 are critical in SARS-CoV-2-induced NET formation and lung inflammation